|
Internal Advisory Committee
Dennis C. Liotta, PhD
 Dennis Liotta is the Samuel Candler Dobbs Professor of Chemistry at Emory University. He received his Ph.D. in organic chemistry in 1974 from The City University of New York and completed his post-doctoral training at The Ohio State University. Dr. Liotta has been a professor at Emory University for thirty years. He is a Fellow of the Alfred P. Sloan Foundation and the recipient of numerous honors and awards including a Camille and Henry Dreyfus Teacher Scholar Fellowship, an Alexander von Humboldt Senior Scientist Award, and the 2005 Herty Award. Additionally, he was named the Emory University Distinguished Faculty Lecturer in 2006.
While at Emory, he has authored more than two hundred research publications and patents. Over the last 15 years he has also developed a great deal of experience in the discovery and development of pharmaceuticals. He has served as a consultant to several major pharmaceutical firms including Merck, GlaxoSmithKline, Burroughs Wellcome, Boehringer Ingelheim, and Johnson & Johnson. Along with his colleague, Raymond Schinazi, he was the recipient of the 2003 Biomedical Industry Growth Award, given by the Georgia Biomedical Partnership. He serves (or has served) on the Scientific Advisory Boards (SAB’s) of several prominent biopharmaceutical companies (MetaStatix (SAB Chair), AtheroGenics, Pharmasset (scientific founder), iThemba Pharmaceuticals (scientific founder, SAB Chair), Slainte Bioceuticals (scientific founder), NeurOp, and FOB Synthesis. In addition, he is the inventor of record for several clinically important antiviral drugs, including FTC (Emtriva, Emtricitabine), Truvada (Emtriva / Viread fixed dose combination), Reverset (DPC 817, D-D4FC), Racivir and Elvucitabine.
Back to Internal Advisory Committee List
|
